Schedule 13G ownership disclosure

BASEL MED GROUP LTD

Ordinary Shares with no par value · CUSIP: G0864B103

Event date: 2025-02-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Rainforest Capital VCC

    Shares: 10,174,579.00 · Class: 54.2%

  • Mengli Chen

    Shares: 10,174,579.00 · Class: 54.2%

  • Keng Leong Fung

    Shares: 10,174,579.00 · Class: 54.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-006759
Form type
SCHEDULE 13G
Filer
Basel Medical Group Ltd
CIK
CIK 2004489
Filed
Apr 30, 2025
Reporting period
Feb 21, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub